Vr Adviser, LLC Lyra Therapeutics, Inc. Transaction History

Vr Adviser, LLC

  • $966 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$4.55 - $6.53 $2,275 - $3,265
500 Added 0.02%
2,576,093 $16 Million
Q4 2023

Feb 14, 2024
BUY
$2.82 - $5.24 $4.66 Million - $8.65 Million
1,651,423 Added 178.69%
2,575,593 $13.5 Million
Q2 2022

Aug 15, 2022
BUY
$4.12 - $7.51 $3.81 Million - $6.94 Million
924,170 New
924,170 $5.22 Million

Others Institutions Holding LYRA

# of Institutions
62
Shares Held
32.2M
Call Options Held
21.1K
Put Options Held
400
View Full List

About Lyra Therapeutics, Inc.

LYRA Quotes by TradingView
  • Ticker LYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,826,400
  • Market Cap $5.73M
  • Description
  • Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...
More about LYRA
Track This Portfolio

Track Vr Adviser, LLC Portfolio

Follow Vr Adviser, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vr Adviser, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email